Ozaki, Toshinori <br/><br/>
Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.  [electronic resource] 

 -  Oncotarget  Nov 2016 
 - 71937-71950 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.12433  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--pharmacology<br/>Apoptosis--drug effects<br/>Cell Cycle Checkpoints<br/>Cell Line, Tumor<br/>Core Binding Factor Alpha 1 Subunit--physiology<br/>Deoxycytidine--analogs & derivatives<br/>Drug Resistance, Neoplasm<br/>Genes, p53<br/>Humans<br/>Membrane Proteins--physiology<br/>Mutation<br/>Pancreatic Neoplasms--drug therapy<br/>Gemcitabine